Research Article

Effect of CUB Domain-containing Protein 1 On Proliferation and Epithelial–Mesenchymal Transition In Nasopharyngeal Carcinoma Cells

DOI:

10.3791/70232

June 5th, 2026

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol aims to investigate the expression and function of CUB domain-containing protein 1 in nasopharyngeal carcinoma, using clinical tissue analysis and in vitro .assays to assess its role in the regulation of epithelial-mesenchymal transition via the ERK1/2 signaling pathway.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol describes a methodological approach to investigate the expression and functional role of CUB domain-containing protein 1 in nasopharyngeal carcinoma and its potential involvement in epithelial-mesenchymal transition. Clinical tissue samples from patients with nasopharyngeal carcinoma and rhinitis were collected to analyze CDCP1 expression using real-time quantitative PCR and immunohistochemistry. In vitro experiments were performed using CNE2 and HK1 nasopharyngeal carcinoma cell lines. CDCP1 overexpression and knockdown were achieved by transfection with a CDCP1 plasmid or specific siRNA. Cell proliferation was assessed by MTT assay, apoptosis was evaluated by Caspase-3 activity measurement, and the expression of EMT-related markers and phosphorylation levels of ERK1/2 were detected by western blot and quantitative PCR. To validate pathway involvement, rescue experiments were conducted using the ERK1/2-specific inhibitor U0126. This protocol provides a systematic in vitro and ex vivo. framework for elucidating the molecular mechanisms by which CDCP1 may regulate tumor progression in nasopharyngeal carcinoma.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Nasopharyngeal carcinoma is the most common primary malignant tumor of the nasopharynx, originating from the nasopharyngeal epithelium, and is a head and neck malignancy with unique geographical distribution characteristics1,2. Approximately 98% of nasopharyngeal carcinoma cases are associated with latent EBV infection. This disease has a high incidence in Asia but is rare in Europe, and its occurrence may be related to dietary habits and other factors3,4,5. According to histological classification, nasopharyngeal carcinoma can be categorized into WHO types I, II, and III6,7,8. Compared with type I, types II and III nasopharyngeal carcinoma are more sensitive to ionizing radiation9; therefore, radiotherapy is widely used in its treatment10,11. However, patients with nasopharyngeal carcinoma still face the risk of tumor cell metastasis, which is one of the leading causes of death12,13. The high recurrence rate highlights the urgent need to clarify the key molecular mechanisms influencing nasopharyngeal carcinoma metastasis and to explore novel biological indicators that can predict metastatic risk.

CUB domain-containing protein 1 (CDCP1) is a membrane protein that plays a driving role in various cancer cells14,15,16. Studies have confirmed that CDCP1 is involved in regulating metastasis in multiple tumors17,18. In lung cancer, CDCP1 expression is upregulated and closely associated with excessive tumor cell proliferation, pathological type, TNM stage, and lymph node metastasis19,20. However, the expression characteristics and function of CDCP1 in nasopharyngeal carcinoma have not yet been reported. Therefore, elucidating the mechanism of CDCP1 in nasopharyngeal carcinoma is of significant clinical importance for revealing its metastatic mechanisms and developing novel intervention targets.

To investigate CDCP1 expression in nasopharyngeal carcinoma and its impact on tumor cell biological behavior, this study employed a strategy combining clinical tissue samples with in vitro cellular experiments. By detecting the expression level of CDCP1 in nasopharyngeal carcinoma tissues and establishing CDCP1. overexpression and silencing models in the nasopharyngeal carcinoma cell line CNE2, cell proliferation was assessed using the MTT assay, apoptosis was evaluated by detecting Caspase-3 activity, and the expression of epithelial-mesenchymal transition (EMT)-related markers as well as the activation status of the ERK1/2 signaling pathway were examined using real-time quantitative PCR and western blot. These methods are widely used in tumor research, offering good reproducibility and ease of operation.

Compared with approaches relying on a single detection method, this study combines multidimensional functional assays with signaling pathway analysis to more systematically evaluate the mechanism of CDCP1 in nasopharyngeal carcinoma. The MTT assay is suitable for high-throughput cell proliferation detection, with simple operation and low cost; Caspase-3 activity detection quantitatively reflects the level of apoptosis; Western blot and qRT-PCR can verify the expression changes of EMT-related factors at the protein and mRNA levels, respectively. Although these methods have certain limitations in terms of mechanistic depth, such as the inability to monitor dynamic changes in signaling pathways in real time, they still provide reliable technical support for preliminary exploration of CDCP1 function.

This study aims to clarify the expression pattern of CDCP1 in nasopharyngeal carcinoma, investigate its mechanism of regulating EMT, tumor cell proliferation, and apoptosis via the ERK1/2 signaling pathway, and thereby provide experimental evidence to elucidate mechanisms of nasopharyngeal carcinoma metastasis and identify potential intervention targets.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study was approved by the Ethics Committee of Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology [Approval No.: 2026IEC(RYJ016)]. All patients provided informed consent, and the collection and use of clinical samples complied with the relevant ethical guidelines of the Declaration of Helsinki. The main experimental materials and instruments used in this study are listed in the Table of Materials.

Collection of clinical tissue samples and detection of CDCP1 expression

Surgical tissue specimens were collected from seven patients diagnosed with nasopharyngeal carcinoma at our hospital between January 2019 and December 2019. Simultaneously, nasal tissue samples from six patients with rhinitis were collected as controls. All tissue samples were immediately frozen in liquid nitrogen after collection for subsequent RNA extraction.

RNA extraction and real-time quantitative PCR detection

Total RNA was extracted from tissue samples according to the manufacturer’s instructions. For each sample, 50–100 mg of tissue was processed on ice in 1 mL of extraction reagent using a tissue homogenizer. Homogenization was carried out for 30 s and repeated 3x to ensure complete disruption of the tissue. After tissue disruption, each lysate received 200 µL of chloroform. The tubes were shaken vigorously by vortexing for 15 s, kept at room temperature for 3 min, and then spun at 12,000 × g. for 15 min at 4 °C to separate the phases. The clear aqueous layer was removed without disturbing the interphase and transferred into a new tube.

RNA was recovered from this aqueous fraction by adding isopropanol at a 1:1 volume ratio. Following a 10 min incubation at room temperature, the samples were centrifuged at 12,000 × g for 10 min at 4 °C to pellet the RNA. The supernatant was discarded, and the pellet was rinsed once with 1 mL of 75% ethanol. After a second centrifugation step at 7,500 × g. for 5 min at 4 °C, the ethanol wash was removed. The RNA pellet was then air-dried for 5–10 min at room temperature and resuspended in 20 µL of RNase-free water. RNA quantity and purity were determined spectrophotometrically.

For cDNA preparation, 1 µg of total RNA was used for reverse transcription. The reaction was carried out at 37 °C for 15 min and then heated to 85 °C for 5 s. Quantitative real-time PCR (qPCR) was subsequently conducted with TB Green Premix Ex Taq II on a Real-Time PCR System. Each 20 µL reaction contained 2 µL of cDNA template, forward and reverse primers at 0.4 µmol/L each, 10 µL of SYBR Green premix, and nuclease-free water. The amplification protocol began with denaturation at 95 °C for 30 s. This was followed by 40 cycles, with each cycle consisting of 95 °C for 5 s and 60 °C for 30 s for annealing/extension. Primer sequences are listed in Table 1.

Immunohistochemical detection of CDCP1 protein expression

Tissue specimens were first fixed in 4% paraformaldehyde for 24 h, followed by standard dehydration, paraffin embedding, and preparation of 4 µm-thick sections. The paraffin sections were then treated with xylene to remove paraffin and rehydrated sequentially through graded ethanol solutions. For antigen unmasking, the slides were placed in citrate buffer (pH 6.0) and heated in a pressure cooker for 3 min after the solution reached boiling. Endogenous peroxidase activity was quenched by exposing the sections to 3% hydrogen peroxide for 10 min.

After blocking of endogenous enzyme activity, the sections were incubated overnight at 4 °C with the anti-CDCP1 primary antibody diluted at 1:200. On the following day, the slides were treated with a horseradish peroxidase-conjugated secondary antibody for 30 min at room temperature. Signal visualization was carried out using a DAB substrate kit, and the sections were subsequently counterstained with hematoxylin. Finally, the slides were dehydrated, mounted, and examined under an optical microscope.

Cell culture and grouping

CNE2 and HK1 human nasopharyngeal carcinoma cells were maintained in high-glucose DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Cells were cultured at 37 °C in an incubator containing 5% CO₂. When cells reached 70%–80% confluence, they were transfected according to the following groups: Control group (Control): transfected with empty vector or negative control siRNA; CDCP1 overexpression group (CDCP1-OE): transfected with CDCP1 overexpression plasmid; CDCP1 silencing group (si-CDCP1): transfected with CDCP1 siRNA; Rescue experiment group (CDCP1-OE + U0126): treated with the ERK1/2-specific inhibitor U0126 (10 µmol/L) for 48 h on the basis of CDCP1. overexpression.

Transfection was carried out according to the manufacturer’s instructions. Cells were plated 24 h before transfection in 6-well plates at 2 × 105 cells/well, with each well containing 2 mL of antibiotic-free medium. Transfection was initiated when the cultures reached approximately 70% confluence. The culture medium was then removed and replaced with fresh serum-free medium. For each well, either 2 µg of plasmid DNA or 100 pmol of siRNA was prepared separately from 5 µL of transfection reagent, with each component diluted in 250 µL of reduced serum-containing medium. Both mixtures were kept at room temperature for 5 min. The diluted nucleic acid and transfection reagent were then combined and allowed to stand for 20 min at room temperature to generate the transfection complexes. These complexes were added to the cells dropwise, gently distributed across the well, and incubated with the cells for 6 h. Once the incubation period was completed, the transfection mixture was removed, and the cells were supplied with complete medium containing 10% FBS.

Cell proliferation assay

At 48 h post transfection, CNE2 and HK1 cells from each group were collected and seeded in 96-well plates at a density of 3 × 103 cells/well with 100 µL of medium per well, with five replicate wells per group. After the cells had been cultured for 24, 48, or 72 h, 10 µL of MTT solution at 5 mg/mL was added to each well. The plates were then incubated again at 37 °C with 5% CO₂ for another 4 h. After this incubation, the culture supernatant was carefully discarded, and 100 µL of dimethyl sulfoxide (DMSO) was added to each well to dissolve the formazan crystals. The plates were agitated for 10 min to ensure complete dissolution. Absorbance was then recorded with a microplate reader at 570 nm, using 630 nm as the reference wavelength.

Apoptosis activity assay

At 48 h post transfection, CNE2 cells from each group were collected, and Caspase-3 activity was detected using a Caspase-3 Activity Assay Kit according to the manufacturer's instructions. A total of 100 µL of lysis buffer was added to 1 × 106 cells, lysed on ice for 15 min, and then centrifuged at 12,000 × g. for 10 min at 4 °C. The resulting supernatant was transferred for subsequent analysis. For the Caspase-3 assay, each well received 50 µL of reaction buffer and 5 µL of Caspase-3 substrate (DEVD-pNA). The plate was then maintained at 37 °C for 2 h, and absorbance was measured at 405 nm with a microplate reader.

Western blot analysis

At 48 h after transfection, CNE2 and HK1 cells from each experimental group were harvested for protein extraction. Cells were disrupted in RIPA buffer containing protease inhibitors and kept on ice for 30 min. The resulting lysates were centrifuged at 12,000 × g for 15 min at 4 °C, after which the supernatant fractions were collected. Protein concentration was measured with a BCA protein assay kit.

For western blot analysis, 30 µg of total protein from each sample was mixed with 5x loading buffer and heated at 100 °C for 10 min to denature the proteins. The samples were separated on 10% SDS-PAGE gels at 120 V for 90 min, followed by transfer onto PVDF membranes at a constant current of 300 mA for 90 min. After transfer, the membranes were blocked with 5% non-fat milk for 1 h at room temperature.

The membranes were incubated overnight at 4 °C with primary antibodies against CDCP1 (1:1,000), E-cadherin (1:1,000), Vimentin (1:1,000), p-ERK1/2 (1:2,000), ERK1/2 (1:1,000), and GAPDH (1:5,000).

On the following day, the membranes were rinsed in TBST 3x, with each wash lasting 10 min. They were then exposed to horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. After three additional TBST washes, the protein signals were visualized using an ECL chemiluminescence substrate. Band intensity was measured with ImageJ software, and GAPDH was used as the normalization control.

Statistical analysis
All experiments were conducted independently 3x. Results are presented as the mean ± standard deviation (SD). Differences among multiple groups were evaluated by one-way analysis of variance (ANOVA), and Tukey’s method was used for pairwise post hoc comparisons. A P-value of < 0.05 was considered statistically significant.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

CDCP1. upregulation in nasopharyngeal carcinoma tissues

The expression level of CDCP1 mRNA in seven nasopharyngeal carcinoma tissues and six rhinitis tissues was detected by real-time quantitative PCR. The results showed that CDCP1 mRNA expression in nasopharyngeal carcinoma tissues was significantly higher than that in rhinitis tissues (P < 0.05, Figure 1A). Furthermore, immunohistochemical staining was performed to ...

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study systematically investigated, for the first time, the expression characteristics of CDCP1 in nasopharyngeal carcinoma tissues and its effects on tumor cell biological behavior, and preliminarily elucidated the molecular mechanism by which CDCP1 promotes epithelial-mesenchymal transition through activation of the ERK1/2 signaling pathway. The findings suggest that CDCP1 exerts a protumorigenic role in nasopharyngeal carcinoma, providing new experimental evidence for understanding the mechanisms of metastasis in ...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors declare that there are no conflicts of interest regarding the publication of this paper. No financial or personal relationships have influenced the work reported in this study.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by the Fujian Natural Science Fund project (No.2017J01271).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BCA Protein Assay KitThermo Fisher, USA23225For protein concentration determination
Caspase-3 Activity Assay KitBeyotime, ChinaC1403Colorimetric assay for Caspase-3 activity
CDCP1 Overexpression PlasmidNot specifiedNot specifiedFor CDCP1 overexpression transfection
CDCP1 Primary AntibodyAbcam, USAab137706For IHC and Western blot; dilution 1:200 (IHC) or 1:1000 (WB)
CDCP1 siRNANot specifiedNot specifiedFor CDCP1 gene silencing
CNE2 Cell LineChina Center for Type Culture Collection (CCTCC), ChinaNot specifiedHuman nasopharyngeal carcinoma cell line
DMEM High Glucose MediumHyClone, USASH30243.01Cell culture
DMSOSigma, USAD2650For dissolving crystals in MTT assay
E-cadherin Primary AntibodyCell Signaling Technology, USA3195SWestern blot; dilution 1:1000
ERK1/2 Primary AntibodyCell Signaling Technology, USA4695SWestern blot; dilution 1:1000
GAPDH Primary AntibodyAbcam, USAab8245Western blot loading control; dilution 1:5000
HK1 Cell LineChina Center for Type Culture Collection (CCTCC), ChinaNot specifiedHuman nasopharyngeal carcinoma cell line
Lipofectamine 2000Invitrogen, USA11668019Transfection reagent
Microplate ReaderBioTek, USANot specifiedAbsorbance detection (MTT, Caspase-3)
MTTSigma, USAM2128Cell proliferation assay; prepared at 5 mg/mL in PBS
Opti-MEMGibco, USA31985070Reduced serum medium for transfection
p-ERK1/2 Primary AntibodyCell Signaling Technology, USA4370SWestern blot; dilution 1:2000
PrimeScript RT Master MixTakara, JapanRR036BReverse transcription reagent for real-time PCR
PVDF MembraneMillipore, USAIPVH00010Protein transfer; 0.45 μm pore size
QuantStudio 5 Real-Time PCR SystemApplied Biosystems, USAA34322qPCR detection
RIPA Lysis BufferBeyotime, ChinaP0039Protein extraction; complete RIPA lysis buffer
Secondary Antibody (HRP-conjugated)Dako, DenmarkNot specifiedFor IHC and Western blot
Sodium Citrate BufferNot specifiedNot specifiedFor IHC antigen retrieval, pH 6.0
TB Green Premix Ex Taq IITakara, JapanRR820AqPCR reaction reagent; 200 reactions
Tissue HomogenizerIKA T10, GermanyNot specifiedFor tissue RNA extraction homogenization
TRIzol ReagentInvitrogen, USA15596026RNA extraction
U0126Selleck, USAS1102ERK1/2-specific inhibitor; used at 10 μmol/L
Vimentin Primary AntibodyCell Signaling Technology, USA5741SWestern blot; dilution 1:1000

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

CUB Domain ProteinCDCP1 ExpressionCell ProliferationReal Time PCRImmunohistochemistryMTT AssayERK1 2 InhibitorWestern Blot

Related Articles